Affiliation:
1. Wuhan University College of Life Sciences
2. Wuhan University
3. Chongqing University
Abstract
Abstract
Studies have suggested a close association between hyperactivation of the catenin beta 1 gene (CTNNB1) and the occurrence and progression of colorectal cancer (CRC). Here, we report that Pyridoxal kinase (PDXK) promotes the development of colorectal cancer through Wnt signaling pathway. The expression of PDXK is elevated in CRC patients and is associated with an unfavourable prognosis. Genetic depletion of PDXK significantly inhibited CRC cell viability, viability, and migration both in vitro and in vivo. Furthermore, we observed that overexpression of PDXK enhanced CRC cell viability, invasion, and migration, and these effects were dependent on its kinase activity. GSEA revealed a strong association between PDXK expression and the Wnt signaling pathway, which was validated through luciferase reporter assays and RT-qPCR. Mechanistically, PDXK was found to activate the Wnt signaling pathway by interacting with GSK-3β and releasing beta-catenin from the GSK-3β destruction complex, thereby promoting tumorigenesis. These findings provide direct insights into the molecular mechanisms underlying the functions of PDXK in CRC and suggest it as a potential therapeutic target for combating colorectal cancer.
Publisher
Research Square Platform LLC
Reference40 articles.
1. NCCN Guidelines Insights: Colon Cancer, Version 2.2018;Benson AB;J Natl Compr Canc Netw,2018
2. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020;Cao W;Chin Med J (Engl),2021
3. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection;Patel SG;Lancet Gastroenterol Hepatol,2022
4. Targeting the WNT Signaling Pathway in Cancer Therapeutics;Tai D;Oncologist,2015
5. Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities;Nusse R;Cell,2017